NCF1 and stroke disorder: The efficacy of apocynin (APO), a NOX2 inhibitor widely used in experimental studies and various stroke models, is well established, and it has been shown to disrupt the translocation of the cytosolic component p47phox to the membrane subunit of the NOX complex [12].